EAST SHORE PARTNERSHIP — All Prescriptions & Medications — Page 11
Practice Code: J82194 | PORTSMOUTH, PO3 6DW
Showing results 501-550 of 653
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Powder 1.4 - 1.6 kcal/ml milkshake with fibre (0913011) | 21 | 322 | £292 | +157.2% ▲ |
| Acetazolamide | 21 | 3,052 | £117 | -3.1% ▼ |
| Tars | 21 | 4,700 | £316 | +150.6% ▲ |
| Adapalene | 21 | 1,080 | £375 | -4.1% ▼ |
| Erythromycin | 21 | 1,290 | £405 | +54.7% ▲ |
| 21 | 510 | £311 | +102.1% ▲ | |
| Zolpidem tartrate | 20 | 259 | £14 | -77.8% ▼ |
| Flupentixol hydrochloride | 20 | 1,412 | £89 | -38.9% ▼ |
| Itraconazole | 20 | 959 | £431 | +49.1% ▲ |
| Estradiol valerate | 20 | 3,304 | £274 | +2.4% ▲ |
| Somatropin | 20 | 90 | £23.2K | +41.1% ▲ |
| Degarelix | 20 | 20 | £2.4K | +15.2% ▲ |
| Heparinoid | 20 | 1,000 | £76 | +53.4% ▲ |
| Other toiletry preparations | 20 | 5,950 | £291 | -53.2% ▼ |
| Valaciclovir | 19 | 722 | £895 | +35.2% ▲ |
| Fesoterodine fumarate | 19 | 980 | £84 | -51.8% ▼ |
| Other oral iron preparations | 19 | 868 | £242 | +92.5% ▲ |
| RtS 2.4 kcal/ml m/sk lower volume, higher protein (0913011) | 19 | 52.5K | £1.1K | -72.8% ▼ |
| Ciclosporin (Eye Anti Inflammatory) | 19 | 840 | £2.0K | -23.4% ▼ |
| Brinzolamide | 19 | 190 | £136 | -85.4% ▼ |
| Paraffin soft white | 19 | 7,600 | £74 | +365.2% ▲ |
| Cocois | 19 | 1,360 | £231 | +38.4% ▲ |
| 19 | 262 | £239 | +73.5% ▲ | |
| 19 | 251 | £815 | +120.9% ▲ | |
| 19 | 660 | £2.5K | -58.0% ▼ | |
| 19 | 350 | £2.0K | +52.1% ▲ | |
| Alverine citrate | 18 | 2,172 | £97 | -56.5% ▼ |
| Hydroxyzine hydrochloride | 18 | 812 | £22 | -66.2% ▼ |
| Liothyronine sodium | 18 | 1,848 | £4.5K | -15.6% ▼ |
| Tacrolimus | 18 | 1,200 | £1.5K | -32.7% ▼ |
| Cinacalcet hydrochloride | 18 | 1,932 | £509 | -22.4% ▼ |
| Powder 2.3 - 2.4 kcal/ml milkshake lower volume (0913011) | 18 | 992 | £514 | -29.9% ▼ |
| Other individually formulated bought in preparations | 18 | 1,290 | £311 | -44.9% ▼ |
| 18 | 1,540 | £269 | -6.9% ▼ | |
| 18 | 180 | £519 | +185.3% ▲ | |
| 18 | 551 | £612 | -13.6% ▼ | |
| 18 | 1,500 | £5.3K | -52.1% ▼ | |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 17 | 952 | £127 | -51.1% ▼ |
| Ciprofibrate | 17 | 616 | £1.5K | +27.3% ▲ |
| Levocetirizine | 17 | 744 | £96 | +9.1% ▲ |
| Riluzole | 17 | 238 | £1.2K | +63.8% ▲ |
| Rifaximin | 17 | 952 | £4.4K | -36.7% ▼ |
| Alprostadil | 17 | 128 | £1.3K | -0.6% vs avg |
| 17 | 54 | £353 | +33.6% ▲ | |
| Sodium picosulfate | 16 | 7,800 | £689 | -55.9% ▼ |
| Zinc oxide | 16 | 421 | £61 | -22.7% ▼ |
| Ciclesonide | 16 | 24 | £518 | +8.7% ▲ |
| Acamprosate calcium | 16 | 2,044 | £217 | -54.1% ▼ |
| Levonorgestrel | 16 | 16 | £1.4K | -57.6% ▼ |
| 16 | 82 | £206 | -34.0% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.